Nursing home costs grow as home health costs stay flat, survey shows

Share this article:
30% of nursing home residents with dementia are undernourished, new global report states
30% of nursing home residents with dementia are undernourished, new global report states

The cost of living in a long-term care facility increased steadily over the last year while home care costs have stayed flat, a new survey finds.

The daily cost for a semi-private skilled nursing facility room grew 3.4% since 2011 to a national median rate of $200 per day, according to a survey conducted by the long-term care insurer Genworth Financial.

The rate for a private SNF room jumped 4.2% since 2011, up to a median daily rate of $222. Assisted living rates saw modest growth at 1.2% since 2011, to a median monthly rate of $3,300. New Jersey came in as the most expensive state for assisted-living facilities, with costs averaging around $5,713 monthly.

By contrast, costs for home health aide services and “homemaker” services, which includes help with cooking or errands saw no growth at all.  According to the Genworth analysis, home care rates stayed low due to “increased competition among agencies and the availability of unskilled labor.”

Genworth said last week it would discontinue some of its long-term care insurance options. Click here to read the full survey results.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.